GET /v1/recalls/drug$0.01hourlytier: utilitycache 3600sEngine D — Gov Data / EDGAR
Latest drug and pharmaceutical recalls across FDA, USDA FSIS, and CPSC in one normalized schema, with severity classing and product details. Same shape as /v1/recalls, pre-filtered to the drug category.
| Name | In | Type | Required | Notes |
|---|---|---|---|---|
q | query | string | no | Match against product, brand, or hazard |
since | query | string | no | |
limit | query | integer | no | (default: 20) |
curl "https://x402-factory.com/v1/recalls/drug?limit=10"
{
"data": {
"recalls": [
{
"agency": "FDA",
"category": "drug",
"product": "Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-410-02",
"brand": "Cipla USA, Inc.",
"hazard": "cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).",
"severity_class": "II",
"recall_date": "2026-06-29",
"remedy": "Voluntary: Firm initiated",
"url": "https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0661-2026%22"
},
{
"agency": "FDA",
"category": "drug",
"product": "Cinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-412-02",
"brand": "Cipla USA, Inc.",
"hazard": "cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).",
"severity_class": "II",
"recall_date": "2026-06-29",
"remedy": "Voluntary: Firm initiated",
"url": "https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0676-2026%22"
},
{
"agency": "FDA",
"category": "drug",
"product": "Cinacalcet Hydrochloride Tablets, 60 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-411-02",
"brand": "Cipla USA, Inc.",
"hazard": "cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).",
"severity_class": "II",
"recall_date": "2026-06-29",
"remedy": "Voluntary: Firm initiated",
"url": "https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0675-2026%22"
},
{
"agency": "FDA",
"category": "drug",
"product": "BD ChloraPrep Hi-Lite Orange, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)), packaged as a) 100 x 10.5 mL applicators/case, NDC 54365-400-35, Catalog Number: 930715NS; b) 100 x 10.5 mL applicators/case, Catalog Number bulk 930715NSB, NDC 54365-400-35; STERILE SOLUTION, C",
"brand": "CareFusion 213, LLC",
"hazard": "Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel",
"severity_class": "II",
"recall_date": "2026-06-11",
"remedy": "Voluntary: Firm initiated",
"url": "https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0643-2026%22"
},
{
"agency": "FDA",
"category": "drug",
"product": "ChloraPrep FREPP, Clear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol) 500 x 1.5 mL applicators/case, STERILE SOLUTION, CareFusion 123, LLC, El Paso, TX, subsidiary of Beckton, Dickson and Co. NDC 54365-400-30, Catalog number 930599NSB",
"brand": "CareFusion 213, LLC",
"hazard": "Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel",
"severity_class": "II",
"recall_date": "2026-06-11",
"remedy": "Voluntary: Firm initiated",
"url": "https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0646-2026%22"
},
{
"agency": "FDA",
"category": "drug",
"product": "BD ChloraPrep CLear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol) 100 x 10.5 mL Applicators/case, STERILE SOLUTION, CareFusion 123, LLC, El Paso, TX, subsidiary of Beckton, Dickson and Co. NDC 54365-400-34, catalog number 930700NS.",
"brand": "CareFusion 213, LLC",
"hazard": "Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel",
"severity_class": "II",
"recall_date": "2026-06-11",
"remedy": "Voluntary: Firm initiated",
"url": "https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0652-2026%22"
},
{
"agency": "FDA",
"category": "drug",
"product": "BD ChloraPrep CLear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol),500 x 1 mL applicators/case, STERILE SOLUTION, CareFusion 123, LLC, El Paso, TX, subsidiary of Beckton, Dickson and Co. NDC 54365-400-31, bulk catalog number 930480NSB",
"brand": "CareFusion 213, LLC",
"hazard": "Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel",
"severity_class": "II",
"recall_date": "2026-06-11",
"remedy": "Voluntary: Firm initiated",
"url": "https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0651-2026%22"
},
{
"agency": "FDA",
"category": "drug",
"product": "BD ChloraPrep Scrub Teal, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol) packaged as a) 25 x 26 mL applicators/case, NDC 54365-400-39, catalog number 930825NS, b) 50 x 26 mL applicators/case, NDC 54365-400-39, bulk catalog number 930825NSB; STERILE SOLUTION, CareFusion 123, LL",
"brand": "CareFusion 213, LLC",
"hazard": "Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel",
"severity_class": "II",
"recall_date": "2026-06-11",
"remedy": "Voluntary: Firm initiated",
"url": "https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0650-2026%22"
},
{
"agency": "FDA",
"category": "drug",
"product": "BD PurPrep, (Povidone-iodine 8.3% w/w (0.83% available iodine) with isopropyl alcohol 72.5% w/w), 50 x 26 mL Applicator/case, STERILE SOLUTION, CAREFUSION 213, LLC, EL PASO, TX 79912, subsidiary of Beckton, Dickson and Co, Catalog Number 960120NSB; NDC 54365-014-42.",
"brand": "CareFusion 213, LLC",
"hazard": "Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel",
"severity_class": "II",
"recall_date": "2026-06-11",
"remedy": "Voluntary: Firm initiated",
"url": "https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0644-2026%22"
},
{
"agency": "FDA",
"category": "drug",
"product": "Accucaine, Kit contains: Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-715-01.",
"brand": "Asclemed USA Inc.",
"hazard": "Lack of Assurance of Sterility",
"severity_class": "II",
"recall_date": "2026-06-08",
"remedy": "Voluntary: Firm initiated",
"url": "https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0658-2026%22"
}
]
},
"meta": {
"endpoint": "/v1/recalls/drug",
"version": "1.0.0",
"generated_at": "2026-08-18T22:54:16.756Z",
"freshness": "hourly",
"sources": [
"openFDA",
"FSIS",
"CPSC"
],
"request_id": "req_00000000",
"docs": "https://x402-factory.com/docs/gov.recalls.drug",
"data_mode": "live"
}
}data payload){
"type": "object",
"properties": {
"recalls": {
"type": "array",
"items": {
"type": "object",
"properties": {
"agency": {
"type": "string",
"enum": [
"FDA",
"USDA",
"CPSC"
]
},
"category": {
"type": "string",
"enum": [
"food",
"drug",
"device",
"consumer",
"vehicle"
]
},
"product": {
"type": "string"
},
"brand": {
"type": "string"
},
"hazard": {
"type": "string"
},
"severity_class": {
"type": "string",
"enum": [
"I",
"II",
"III"
]
},
"recall_date": {
"type": "string"
},
"remedy": {
"type": "string"
},
"url": {
"type": "string"
}
},
"required": [
"agency",
"category",
"product",
"hazard",
"severity_class",
"recall_date",
"url"
],
"additionalProperties": false
}
}
},
"required": [
"recalls"
],
"additionalProperties": false
}
The platform wraps every payload in an envelope: { "data": …, "meta": { endpoint, version, generated_at, freshness, sources, request_id, docs, data_mode } }.
Unpaid requests receive 402 with payment requirements (accepts). Pay $0.01 in USDC on Base per call via an X-PAYMENT header — see docs.x402.org. With PAYMENT_MODE=disabled (local dev) the endpoint is open.
| Status | Code | Meaning |
|---|---|---|
| 400 | INVALID_PARAMS | Input failed validation; message lists the offending fields. |
| 404 | NOT_FOUND | No matching resource; suggestion may point to a sibling endpoint. |
| 410 | RESOLVED | Market/event settled; body includes a resolution summary. |
| 503 | STALE_DATA | Upstream feed down; stale data is never silently served beyond 2× cache TTL. |
| 500 | INTERNAL | Our bug. The request_id helps us find it. |